Nov
20
to Nov 22

4th NeoAntigen Summit

SapVax’s Chief Scientific Officer, Claudine Bruck will be serving on a panel at the NeoAg Summit in Boston, MA on Friday, November 22 @ 8:15-9am. The panel discussion is entitled “The clinical potential and challenges of neoantigen-based therapies with immunotherapy combinations.”

View Event →